peptide therapy cjc-1295 + ipamorelin blend benefits studies cjc-1295 ipamorelin blend benefits studies CJC 1295 Ipamorelin: The Benefits of cjc-1295 ipamorelin peptide therapy Rejuvenate

doi: 10.1016/j.joca.2021.06.013 21 MobasheriABondyCAMoleyKMendesAFRosaSCRichardsonSet al

Tian, L., Wu, D., Dasgupta, A., Chen, K

By further elucidating the pathogenic mechanism by which hepatic iron accumulation triggers ferroptosis through the c-Myc-Acsl4 regulatory axis, thereby accelerating the progression of metabolic-associated steatohepatitis (MASH), our research team identified a novel iron chelator, FOT1 (FerroTerminator1, formerly known as CN128), through drug screening, which can prevent and treat the onset and progression of MASH disease [117]

Additionally, increased levels of iron in specific brain regions further augment neuronal vulnerability to oxidative stress (29)